Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

Medicine & Life Sciences

• SARS Virus 100%
• Point-of-Care Systems 76%
• Antigens 43%
• Confidence Intervals 40%
• Infections 32%
• Reverse Transcription 21%
• Polymerase Chain Reaction 17%
• Preprints 16%
• Biosensing Techniques 11%
• Routine Diagnostic Tests 9%
• Sensitivity and Specificity 7%
• Public Health 6%
• Containment of Biohazards 6%
• Selection Bias 5%
• North America 5%
• Pandemics 5%
• Population Groups 4%
• Global Health 4%
• Viral Load 4%
• Patient Selection 4%
• Signs and Symptoms 4%
• Risk Assessment 4%
• Publications 4%
• PubMed 3%
• Language 3%
• Patient Care 3%
• Data Analysis 3%
• Cohort Studies 3%
• Databases 2%
• Equipment and Supplies 2%